Frontera Therapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • IPO Registration

  • Employees
  • 54

Employees

  • Latest Deal Type
  • IPO
  • (Announced)

  • Investors
  • 8

Frontera Therapeutics General Information

Description

Developer of gene therapies designed for the treatment of genetic disorders. The company's technology platform utilizes adeno-associated virus vectors and an insect cell expression system, enabling healthcare professionals to provide treatments for patients with ophthalmology and cardiology diseases.

Contact Information

Website
www.fronteratherapeutics.com
Ownership Status
In IPO Registration
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 1001, Block C, Changtai Plaza, Lane 2889
  • Jinke Road, Pudong New Area
  • Shanghai, 201203
  • China
+86 021
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • Room 1001, Block C, Changtai Plaza, Lane 2889
  • Jinke Road, Pudong New Area
  • Shanghai, 201203
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Frontera Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. IPO 28-Aug-2026 Announced Clinical Trials - Phase 2
6. Early Stage VC (Series B2) 21-Jul-2022 Completed Pre-Clinical Trials
5. Early Stage VC (Series B1) 06-May-2021 Completed Pre-Clinical Trials
4. Early Stage VC (Series A) 15-Jan-2021 Completed Startup
3. Seed Round 25-May-2020 Completed Startup
2. Seed Round 28-Apr-2020 Completed Startup
1. Accelerator/Incubator 17-Sep-2019 Completed Startup
To view Frontera Therapeutics’s complete valuation and funding history, request access »

Frontera Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of gene therapies designed for the treatment of genetic disorders. The company's technology platform utilizes
Drug Discovery
Shanghai, China
54 As of 2026

Charlottesville, VA
 

Grand Rapids, MI
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Frontera Therapeutics Competitors (2)

One of Frontera Therapeutics’s 2 competitors is HemoShear Therapeutics, a Venture Capital-Backed company based in Charlottesville, VA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
HemoShear Therapeutics Venture Capital-Backed Charlottesville, VA
Cirius Therapeutics Venture Capital-Backed Grand Rapids, MI
You’re viewing 2 of 2 competitors. Get the full list »

Frontera Therapeutics Patents

  • 13

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 8

    Pending

  • Expiring in next 12 mo

Frontera Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025235632-A2 Methods for generating rhabdovirus-free cell line Pending 08-May-2024
WO-2025235632-A3 Methods for generating rhabdovirus-free cell line Pending 08-May-2024
WO-2025207456-A1 Methods for purification of adeno associated virus particles by anion exchange chromatography Pending 25-Mar-2024
AU-2022298827-A1 Composition and method for treating hemophilia b Inactive 23-Jun-2021
EP-4361278-A1 Composition and method for treating hemophilia b Inactive 23-Jun-2021 C12N9/6408
To view Frontera Therapeutics’s complete patent history, request access »

Frontera Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Frontera Therapeutics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Boyu Capital Asset Manager Minority
HSG (Hong Kong) Venture Capital Minority
Loyal Valley Capital Growth/Expansion Minority
Starr International Company PE/Buyout Minority
Terra Magnum Capital Partners PE/Buyout Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Frontera Therapeutics FAQs

  • When was Frontera Therapeutics founded?

    Frontera Therapeutics was founded in 2019.

  • Where is Frontera Therapeutics headquartered?

    Frontera Therapeutics is headquartered in Shanghai, China.

  • What is the size of Frontera Therapeutics?

    Frontera Therapeutics has 54 total employees.

  • What industry is Frontera Therapeutics in?

    Frontera Therapeutics’s primary industry is Drug Discovery.

  • Is Frontera Therapeutics a private or public company?

    Frontera Therapeutics is a Private company.

  • What is Frontera Therapeutics’s current revenue?

    The current revenue for Frontera Therapeutics is .

  • How much funding has Frontera Therapeutics raised over time?

    Frontera Therapeutics has raised $195M.

  • Who are Frontera Therapeutics’s investors?

    Boyu Capital, HSG (Hong Kong), Loyal Valley Capital, Starr International Company, and Terra Magnum Capital Partners are 5 of 8 investors who have invested in Frontera Therapeutics.

  • Who are Frontera Therapeutics’s competitors?

    HemoShear Therapeutics and Cirius Therapeutics are competitors of Frontera Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process